| Ticker: ESCP | 4828 Sterling Drive | |
| Exchange: NASDAQ-National Market | Boulder, Colorado 80301 | |
| Industry: Wholesale | (303) 444-2600 |
| Type of Shares: | Common Shares | Filing Date: | 4/26/96 | |
| U.S. Shares: | 1,200,000 | Offer Date: | 6/25/96 | |
| Non-U.S. Shares: | 0 | Filing Range: | $12.00 - $14.00 | |
| Primary Shares: | 1,200,000 | Offer Price: | $10.50 | |
| Secondary Shares: | 0 | Gross Spread: | $0.84 | |
| Offering Amount: | $15,600,000 | Selling: | $0.51 | |
| Expenses: | $300,000 | Reallowance: | $0.10 | |
| Shares Out After: | 5,290,386 |
| Manager | Tier | Phone |
| John G. Kinnard | Lead Manager | (612) 370-2922 |
| Auditor: Arthur Andersen | |||||
| Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| 3/31/96 | 3/31/96 | ||||
| Revenue: | $2.17 | Assets: | $1.83 | ||
| Net Income: | -$1.31 | Liabilities: | $0.60 | ||
| EPS: | -$0.33 | Equity: | $1.23 | ||
Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year, unaudited figures are partial year | |||||
| Business Description |
| The company manufactures an electrosurgical shielding system and integrated electrosurgical instruments designed to protect the surgical patient against stray electrical energy. The Company's Electroshield Monitoring System is based on the "Active Electrode Monitoring" concept developed and patented by the Company. The Company has received 510(k) notifications from the Food and Drug Administration for the system and related products. The complete system consists of the Company's EM-2 Electronic Monitor, which plugs directly into a standard electrosurgical generator, and integrated electrosurgical instruments manufactured by the Company that incorporate the Company's shielding technology. The Company also has developed a protective sheath incorporating its AEM technology for use with unshielded laparoscopic and specialty instruments not manufactured by the Company. The AEM system is transparent to the surgeon, providing enhanced safety without any change in the methodology used to perform MIS electrosurgery. |
| Use of Proceeds |
| The proceeds from the offering will be used for working capital and for general corporate purposes. |
©1996 IPO Data Systems, Inc. - All rights reserved.